Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-24-000441

Director bought 1,000 shares at an average $12.75 ($12,750)

From the SEC's structured data for this filing

Trades in this filing

Almenoff June Sherie · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-12 Purchase : show line 1 in the form +500 $12.50 $6,250 500 I
2024-11-13 Purchase : show line 2 in the form +500 $13.00 $6,500 1,000 I
Open-market purchases · 1,000 sh · avg $12.75 · $12,750
Loading xslF345X05/primary_doc.xml…